Pfizer Limited — Others, 22-07-2025: Shareholders meeting

Pfizer Limited shareholders have overwhelmingly approved all resolutions at the 74th Annual General Meeting. Key approvals include the adoption of the company's audited financial statements for the financial year ended March 31, 2025, and the declaration of a dividend of ₹165 per equity share. Additionally, shareholders sanctioned the re-appointment of Mr. Amit Agarwal as a Director and ratified the remuneration for cost auditors, alongside the appointment of secretarial auditors. This outcome underscores strong investor support for the company's financial performance and governance.